New Animal Models and Pre-Clinical Screening Methodology for Psychiatric Drug Development
The University of Haifa's Gal Laboratory headed by Prof. Gal Richter-Levin has developed novel, predictive preclinical models and more reliable complex screening methodologies which overcome shortcoming of previous animal models. These advanced tools are offered to pharmaceutical companies in the field both as drug-screening platforms that are able to reliably identify properties of drugs relevant to human symptomology, and as an effective platform for identifying relevant novel candidates.
The Brain and Behavior Laboratory Services
- Established novel and unique behavioral animal models for anxiety, post-traumatic stress disorder and depression.
- For effective drug screening
- For identifying novel candidates for drug development - A multidisciplinary approach for designing the preclinical models suitable to the most relevant symptoms of a specific disorder, including classical electrophysiological parameters, behavioral parameters and unique data analysis methods.
- Biochemical and electrophysiological measurements and analysis power.
- A committed scientific team with the relevant experience and expertise to develop and set up relevant rodent models.
Related Pages
New Animal Models and Pre-Clinical Screening Methodology for Psychiatric Drug Development
